|
|
|
|
Preface to the First Edition. |
|
|
|
|
|
|
1.1 What are Clinical Trials? |
|
|
|
1.2 History of Clinical Trials. |
|
|
|
1.3 Regulatory Process and Requirements. |
|
|
|
1.4 Investigational New Drug Application. |
|
|
|
1.5 New Drug Application. |
|
|
|
1.6 Clinical Development and Practice. |
|
|
|
1.7 Aims and Structure of the Book. |
|
|
|
2. Basic Statistical Concepts. |
|
|
|
|
|
|
2.2 Uncertainty and Probability. |
|
|
|
2.3 Bias and Variability. |
|
|
|
2.4 Confounding and Interaction. |
|
|
|
2.5 Descriptive and Inferential Statistics. |
|
|
|
2.6 Hypothesis Testing and p-Values. |
|
|
|
2.7 Clinical Significance and Clinical Equivalence. |
|
|
|
2.8 Reproducibility and Generalizability. |
|
|
|
3. Basic Design Considerations. |
|
|
|
|
|
|
3.2 Goals of Clinical Trials. |
|
|
|
3.3 Target Population and Patient Selection. |
|
|
|
3.4 Selection of Controls. |
|
|
|
3.5 Statistical Considerations. |
|
|
|
|
|
|
|
|
|
4. Randomization and Blinding. |
|
|
|
|
|
|
4.2 Randomization Models. |
|
|
|
4.3 Randomization Methods. |
|
|
|
4.4 Implementation of Randomization. |
|
|
|
4.5 Generalization of Controlled Randomized Trials. |
|
|
|
|
|
|
|
|
|
5. Designs for Clinical Trials. |
|
|
|
|
|
|
5.2 Parallel Group Designs. |
|
|
|
5.3 Cluster Randomized Designs. |
|
|
|
|
|
|
|
|
|
|
|
|
5.7 Group Sequential Designs. |
|
|
|
5.8 Placebo-Challenging Design. |
|
|
|
5.9 Blinded Reader Designs. |
|
|
|
|
|
|
6. Designs for Cancer Clinical Trials. |
|
|
|
|
|
|
6.2 General Considerations for Phase I Cancer Clinical Trials. |
|
|
|
6.3 Single-Stage Up-and-Down Phase I Designs. |
|
|
|
6.4 Two-Stage Up-and-Down Phase I Designs. |
|
|
|
6.5 Continual Reassessment Method Phase I Designs. |
|
|
|
6.6 Optimal/Flexible Multiple-Stage Designs. |
|
|
|
6.7 Randomized Phase II Designs. |
|
|
|
|
|
|
7. Classification of Clinical Trials. |
|
|
|
|
|
|
|
|
|
|
|
|
7.4 Active Control and Equivalence/Noninferiority Trials. |
|
|
|
7.5 Dose-Response Trials. |
|
|
|
|
|
|
|
|
|
7.8 Vaccine Clinical Trials. |
|
|
|
|
|
|
8. Analysis of Continuous Data. |
|
|
|
|
|
|
|
|
|
|
|
|
8.4 Analysis of Variance. |
|
|
|
8.5 Analysis of Covariance. |
|
|
|
|
|
|
|
|
|
|
|
|
9. Analysis of Categorical Data. |
|
|
|
|
|
|
9.2 Statistical Inference for One Sample. |
|
|
|
9.3 Inference of Independent Samples. |
|
|
|
9.4 Ordered Categorical Data. |
|
|
|
9.5 Combining Categorical Data. |
|
|
|
|
|
|
9.7 Repeated Categorical Data. |
|
|
|
|
|
|
10. Censored Data and Interim Analysis. |
|
|
|
|
|
|
10.2 Estimation of the Survival Function. |
|
|
|
10.3 Comparison between Survival Functions. |
|
|
|
10.4 Cox’s Proportional Hazard Model. |
|
|
|
10.5 Calendar Time and Information Time. |
|
|
|
10.6 Group Sequential Methods. |
|
|
|
|
|
|
11. Sample Size Determination. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.6 Dose-Response Studies. |
|
|
|
|
|
|
11.8 Equivalence and Noninferiority Trials. |
|
|
|
11.9 Multiple-Stage Design in Cancer Trials. |
|
|
|
11.10 Comparing Variabilities. |
|
|
|
|
|
|
12. Issues in Efficacy Evaluation. |
|
|
|
|
|
|
12.2 Baseline Comparison. |
|
|
|
12.3 Intention-to-Treat Principle and Efficacy Analysis. |
|
|
|
12.4 Adjustment for Covariates. |
|
|
|
|
|
|
|
|
|
|
|
|
12.8 Use of Genetic Information for Evaluation of Efficacy. |
|
|
|
12.9 Sample Size Re-estimation. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.3 Coding of Adverse Events. |
|
|
|
13.4 Analysis of Adverse Events. |
|
|
|
13.5 Analysis of Laboratory Data. |
|
|
|
|
|
|
14. Preparation and Implementation of a Clinical Protocol. |
|
|
|
|
|
|
14.2 Structure and Components of a Protocol. |
|
|
|
14.3 Points to Be Considered and Common Pitfalls during Development and Preparation of a Protocol. |
|
|
|
14.4 Common Departures for Implementation of a Protocol. |
|
|
|
14.5 Monitoring, Audit, and Inspection, 617 |
|
|
|
14.6 Quality Assessment of a Clinical Trial. |
|
|
|
|
|
|
15. Clinical Data Management. |
|
|
|
|
|
|
15.2 Regulatory Requirements. |
|
|
|
15.3 Development of Case Report Forms. |
|
|
|
15.4 Database Development. |
|
|
|
15.5 Data Entry, Query, and Correction. |
|
|
|
15.6 Data Validation and Quality. |
|
|
|
15.7 Database Lock, Archive, and Transfer. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|